Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Grants for Young Researchers
Young researchers are especially feeling the funding squeeze. The percentage of new investigators winning a combined $1.593 billion in funding during FY 2012 is slightly less than the 15.3% success rate for all new NIH grant applications, and half the percentage for established investigators, according to agency figures. More sobering for younger researchers, however, is how the age of first-time R01 grant winners has leveled off since 2000 to around 42 years old for Ph.D.s, 44 years old for combined M.D./Ph.D.s, and about 45 for M.D.s. (Find out more about this here.) Have you been feeling the squeeze?